Trials / Recruiting
RecruitingNCT06819410
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
A Retrospective Clinical Study on the Efficacy and Safety of Amphotericin B Compared With Azoles in the Treatment of Invasive Fungal Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Sichuan Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Efficacy and safety of amphotericin B and azoles in the treatment of invasive fungal disease
Detailed description
The medical records, demographic characteristics and clinical data of patients with invasive fungal disease treated with amphotericin B or azoles were collected through the electronic medical record system of Sichuan Provincial People's Hospital from 2021 to 2024. To evaluate the efficacy and safety of these two types of drugs.
Conditions
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2025-02-11
- Last updated
- 2025-02-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06819410. Inclusion in this directory is not an endorsement.